Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction
A consistent prevalence of antibodies to the current B/Yamagata vaccine strain in the general population was observed. The prolonged use of a well-matched influenza vaccine and a low antigenic diversity of B/Yamagata viruses may have facilitated a strong reduction in B/Yamagata circulation, potentially contributing to the disappearance of this lineage.
Authors
- Otfried Kistner (ORCID: https://orcid.org/0000-0003-0828-9550)
- Marco Bruttini (ORCID: https://orcid.org/0000-0003-1063-2522)
- Serena Marchi (ORCID: https://orcid.org/0000-0002-6817-2461)
- Claudia Maria Trombetta (ORCID: https://orcid.org/0000-0001-7229-9919)
- Giovanna Milano (ORCID: https://orcid.org/0000-0001-8800-760X)
- Elena Pariani (ORCID: https://orcid.org/0000-0001-5681-3455)
- Ilaria Manini (ORCID: https://orcid.org/0000-0002-5877-3095)
- Alessandro Manenti (ORCID: https://orcid.org/0000-0002-4027-7296)
- Nigel James Temperton (ORCID: https://orcid.org/0000-0002-7978-3815)
- Emanuele Montomoli (ORCID: https://orcid.org/0000-0001-7595-4974)
- Maria Chironna (ORCID: https://orcid.org/0000-0002-1043-1256)
Institutions
- University of Siena (IT)
- Medway School of Pharmacy (GB)
- University of Milan (IT)
- University of Kent (GB)
- VisMederi Research (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Influenza and Other Respiratory Viruses
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1111/irv.13359
- Citations
- 7
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71